Novel artificial intelligence-based identification of drug-gene-disease interaction using protein-protein interaction.
Ontology highlight
ABSTRACT: The evaluation of drug-gene-disease interactions is key for the identification of drugs effective against disease. However, at present, drugs that are effective against genes that are critical for disease are difficult to identify. Following a disease-centric approach, there is a need to identify genes critical to disease function and find drugs that are effective against them. By contrast, following a drug-centric approach comprises identifying the genes targeted by drugs, and then the diseases in which the identified genes are critical. Both of these processes are complex. Using a gene-centric approach, whereby we identify genes that are effective against the disease and can be targeted by drugs, is much easier. However, how such sets of genes can be identified without specifying either
SUBMITTER: Taguchi YH
PROVIDER: S-EPMC11653834 | biostudies-literature | 2024 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA